Test Price
2,800 AED✅ Home Collection Available
ATP2A1 Gene Brody Myopathy Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ATP2A1 لاعتلال برودي العضلي NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – ملخص تنفيذي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Next Generation Sequencing (NGS) workflow.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM‑ 11 PM).
- Clinical Guidance: Post‑Test Clinical Interpretation by DHA‑Licensed Specialists available via telephonic consultation.
- Insurance: Direct Billing Verification – WhatsApp +971 54 548 8731.
- دقة تشخيصية فائقة بنسبة 99.9% وفق معايير هيئة الصحة بدبي، مع خدمة جمع العينات المنزلية المعتمدة.
Clinical Overview
The ATP2A1 Gene Brody Myopathy Genetic Test detects pathogenic mutations in the ATP2A1 gene using Genetic Test empowers neurologists and clinical geneticists to confirm the diagnosis, forecast prognosis, and inform family planning.
نظرة عامة: يكشف تحليل تسلسل الجيل التالي لجين ATP2A1 عن الطفرات المسببة لمرض برودي العضلي النادر، مما يوفر تشخيصًا جزيئيًا دقيقًا وخطة علاجية مخصصة.
| Feature | Our Test (NGS Panel) | Closest Alternative (Sanger / WES) |
|---|---|---|
| Methodology | Next Generation Sequencing (full gene) | Sanger sequencing (single exon) or Whole Exome Sequencing |
| Diagnostic Sensitivity | >99.9% for coding regions | Variable; may miss deep intronic variants |
| Reporting Time | 3–4 Weeks | 4–8 Weeks (WES) / 2–4 Weeks (Sanger) |
| Included Pre‑Test Support | Genetic Counselling & Pedigree Chart | May require separate referral |
Clinical Perspective from DHA‑Licensed Specialist
“As a clinical neurologist, I want to reassure you that this genetic test is safe and painless, yet I urge you to interpret the results only with a specialist who understands your full clinical picture. Unexpected findings can bring emotional stress, and no result should lead to medication changes without expert consultation. Always keep your physician at the centre of your care.”
Dr. PRABHAKAR REDDY, DHA License: 61713011 – Consultant Neurologist
Safety & Exclusion Criteria
- Inability to provide informed consent (or legal guardian consent for minors under UAE Child Protection Law, Federal Decree‑Law No. 3 of 2016).
- Acute severe illness where phlebotomy may pose a risk; consultation with our medical team is required.
- The test does not replace emergency clinical care.
🚨 Emergency Red Flags — Seek Immediate Medical Attention:
- Sudden severe muscle weakness or inability to walk
- Difficulty breathing or swallowing
- Chest pain, irregular heartbeat, or fainting
⚠️ Do not discontinue any prescribed medication without consulting your treating physician. Genetic results alone do not dictate treatment modifications.
Patient FAQ & Clinical Guidance
What is the purpose of the ATP2A1 gene test?
This test identifies ATP2A1 gene mutations responsible for Brody myopathy to confirm diagnosis and guide clinical management. The result is interpreted by a neurologist or clinical geneticist and may influence physical therapy and surveillance for cardiomyopathy.
يكشف هذا الاختبار طفرات جين ATP2A1 المسببة لمرض برودي العضلي لتأكيد التشخيص وتوجيه الإدارة السريرية. يتم تفسير النتيجة من قبل طبيب أعصاب أو أخصائي وراثة سريرية وقد تؤثر على خطة العلاج الطبيعي ومراقبة عضلة القلب.
How is the sample collected and is home collection available?
A trained phlebotomist collects 2–3 mL of whole blood in an EDTA tube, or a dried blood spot on an FTA card; home collection runs daily from 8 AM to 11 PM across all Emirates. No fasting is required, and the process takes under 10 minutes.
يقوم فني مختص بسحب 2-3 مل من الدم الكامل في أنبوب EDTA أو بقعة دم جافة على بطاقة FTA؛ وتتوفر خدمة السحب المنزلي يوميًا من 8 صباحًا حتى 11 مساءً في جميع الإمارات. لا يتطلب الاختبار صيامًا، ويستغرق أقل من 10 دقائق.
What can I expect after I receive my results?
You will receive a detailed molecular report and a 15-minute telephonic clinical guidance session with a specialist. If a pathogenic variant is found, the report will include a personalized risk assessment for family members and recommendations for further cardiac or neurological evaluations.
ستتلقى تقريرًا جزيئيًا مفصلًا وجلسة إرشاد سريري هاتفية مدتها 15 دقيقة مع أخصائي. إذا تم اكتشاف طفرة ممرضة، سيتضمن التقرير تقييمًا شخصيًا للمخاطر لأفراد العائلة وتوصيات لتقييمات قلبية وعصبية إضافية.
Pre‑Test Requirements & Specimen Logistics
- A detailed clinical history and a Genetic Counselling session are mandatory before testing; a pedigree chart of family members affected by Brody myopathy will be drawn.
- Acceptable specimens: Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card (one drop sufficient).
- Specimens are transported in ISO‑certified cold‑chain packaging immediately after collection.
UAE Regulatory Compliance
- This is ordered and interpreted in accordance with Federal Decree‑Law No. 41 of 2024 (Art. 87) on Health Data Privacy and Security.
- Minors must provide documentation of legal guardian consent as required by UAE Child Protection Law (Federal Decree‑Law No. 3 of 2016 and subsequent amendments for genetic testing).
- All personal data is processed under UAE PDPL (Federal Decree‑Law No. 45 of 2021); genetic data is anonymised after reporting.
- Laboratory accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139); DHA Facility License: 9834453.
Support & WhatsApp: +971 54 548 8731 | Email: care@dnalabsuae.ae
Home Collection Hours: 8:00 AM – 11:00 PM, 7 days a week across all Emirates.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians